Akeso, Inc. (9926.HK)

HKD 87.8

(1.8%)

EBITDA Summary of Akeso, Inc.

Akeso, Inc.'s latest annual EBITDA in 2023 was 2.17 Billion CNY , up 246.64% from previous year.
Akeso, Inc.'s latest quarterly EBITDA in 2024 Q2 was -304.46 Million CNY , down 0.0% from previous quarter.
Akeso, Inc. reported an annual EBITDA of -1.27 Billion CNY in 2022, down -9.84% from previous year.
Akeso, Inc. reported an annual EBITDA of -1.31 Billion CNY in 2021, down -30.59% from previous year.
Akeso, Inc. reported a quarterly EBITDA of -488.05 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Akeso, Inc. reported a quarterly EBITDA of N/A for 2023 FY, up 246.64% from previous quarter.

Annual EBITDA Chart of Akeso, Inc. (2023 - 2018)

Historical Annual EBITDA of Akeso, Inc. (2023 - 2018)

Year	EBITDA	EBITDA Growth
2023	2.17 Billion CNY	246.64%
2022	-1.27 Billion CNY	-9.84%
2021	-1.31 Billion CNY	-30.59%
2020	-1 Billion CNY	-260.62%
2019	-279.51 Million CNY	-98.25%
2018	-140.99 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-304.46 Million CNY	0.0%
2023 Q4	-488.05 Million CNY	0.0%
2023 FY	- CNY	246.64%
2023 Q2	2.38 Billion CNY	0.0%
2022 FY	- CNY	-9.84%
2022 Q2	-706.89 Million CNY	0.0%
2022 Q4	-738.95 Million CNY	0.0%
2021 Q4	-824.25 Million CNY	0.0%
2021 FY	- CNY	-30.59%
2021 Q2	-492.06 Million CNY	0.0%
2020 FY	- CNY	-260.62%
2020 Q2	-333.13 Million CNY	0.0%
2020 Q4	-674.86 Million CNY	0.0%
2019 Q2	-130.47 Million CNY	0.0%
2019 FY	- CNY	-98.25%
2019 Q4	-149.04 Million CNY	0.0%
2018 Q2	-31.67 Million CNY	0.0%
2018 Q4	-78.28 Million CNY	0.0%
2018 FY	- CNY	0.0%
2018 Q1	-31.67 Million CNY	0.0%
2017 Q4	-31.67 Million CNY	0.0%

Peer EBITDA Comparison of Akeso, Inc.

Name	EBITDA	EBITDA Difference
Uni-Bio Science Group Limited	91.23 Million HKD	-2280.998%
CK Life Sciences Int'l., (Holdings) Inc.	486.79 Million HKD	-346.24%